The Radiant Logistics, Inc. 2021 Omnibus Incentive Plan (the “2021 plan”) permits the Company’s Audit and Executive Oversight Committee to grant share-based awards to eligible employees, non-employee directors, and consultants of the Company. The 2021 plan became effective immediately upon approval by the Company’s stockholders and will expire on November 16, 2031, unless terminated earlier by the Board. The 2021 plan replaced the 2012 Radiant Logistics, Inc. Stock Option and Performance Award Plan (the “2012 plan”). The remaining shares available for grant under the 2012 plan will roll over into the 2021 plan, and no new awards will be granted under the 2012 plan. The terms of the 2012 plan, as applicable, will continue to govern awards outstanding under the 2012 plan, until

exercised, expired, paid or otherwise terminated or canceled. Other than the 2021 plan, there are no other equity compensation plans under which equity awards can be granted. As of June 30, 2026, there are 1,936,984 shares available for grant under the 2021 Plan.

The Company recognized share-based compensation expense related to restricted stock units of $1,594 and share-based compensation benefit of $890 for the fiscal years ended June 30, 2026 and 2025, respectively. As of June 30, 2026, the Company had approximately $3,058 of total unrecognized share-based compensation cost for restricted stock units expected to be recognized over a weighted average period of approximately 1.96 years.

The following table summarizes restricted stock unit activity:


	Number of Units			Weighted Average Grant Date Fair Value
Unvested balance as of June 30, 2025		1,468,057		$	6.60
Vested		(258,408	)		6.79
Granted		708,981			6.21
Forfeited/Cancelled		(298,908	)		6.46

Unvested balance as of June 30, 2026		1,619,722		$	6.42

The table above includes 1,018,666 and 892,578 PSUs with performance-based conditions as of June 30, 2026 and 2025, respectively. These awards will vest upon achievement of pre-established individual and Company performance goals as measured after a three-year period.

Stock options are granted at exercise prices equal to the fair value of the common stock at the date of the grant and have a term of ten years. Generally, grants under each plan vest 20% annually over a five-year period from the date of grant. The Company recognized share-based compensation expense related to stock options of $66 and $71 for the fiscal years ended June 30, 2026 and 2025, respectively. The aggregate intrinsic value of options exercised was $727 and $1,165 for the fiscal years ended June 30, 2026 and 2025, respectively.

The following table summarizes stock option activity:


	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value (In thousands)
Outstanding as of June 30, 2025		285,000		$	4.89		2.54	$	476
Exercised		(185,000	)		3.51		—		727

Outstanding as of June 30, 2026		100,000		$	7.45		4.93	$	201

Exercisable as of June 30, 2026		100,000		$	7.45		4.93	$	201